The Heart

📊 JAMA Clinical Guidelines Synopsis: The 2025 guideline for management recommends dual antiplatelet therapy with aspirin and a P2Y12 inhibitor, high-intensity statins, invasive revascularization, and radial access for angiography.

ja.ma/4e7QU0g

Monitoring cardiac symptoms during teleprehabilitation prior to coronary artery bypass grafting: a digital cardiac counseling trial subanalysis ow.ly/crRf50Z4vCY

(HF) affects more than 64 million individuals worldwide, and acute HF is associated with 1-year mortality rates of 23.6% in North America and Europe.

Cardiac resynchronization therapy restores synchronous ventricular activation in patients with HF, reduced LVEF, and left bundle-branch block, or in those requiring chronic ventricular pacing, and may improve LV function, decrease HF hospitalizations, and reduce mortality. 🧵

🔗 Learn more in this JAMA Review: ja.ma/4uxZhrM

The Role of Imaging in Aortic Dissection and Related Syndromes

https://www.jacc.org/doi/10.1016/j.jcmg.2013.10.015

🗞️ Current state of knowledge on the
epidemiology, aetiology, diagnosis, &
management of heart involvement in
eosinophilia.
Consensus Statement of WG on Myocardial & Pericardial Disease


bit.ly/42Xcsqb

📄 Multicentre study (Addis Ababa, ; n=154; no reperfusion)
• STEMI: 79.9%
• Median delay: 24 h
• Mortality: 26.6%; predictors: age↑, female s*x, RR↑, SBP↓
• Highlights urgent need for access & reduced prehospital delay
https://link.springer.com/article/10.1186/s12872-026-05850-5